How big is OrthoPediatrics Corp.?

As of Jun 18, OrthoPediatrics Corp. has a market capitalization of 504.55 million, with recent net sales of 212.45 million and a net loss of 40.68 million for the latest four quarters. As of December 2024, shareholder's funds were 354.57 million and total assets were 483.70 million.

Market Cap: As of Jun 18, OrthoPediatrics Corp. has a market capitalization of 504.55 million, classifying it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters ending in March 2025, the company reported net sales of 212.45 million. During the same period, the consolidated net profit was a loss of 40.68 million.<BR><BR>Balance Sheet Snapshot: As of December 2024, the company's shareholder's funds amounted to 354.57 million, while total assets were reported at 483.70 million.

What does OrthoPediatrics Corp. do?

OrthoPediatrics Corp. is a medical device company specializing in products for the pediatric orthopedic market, with recent net sales of $52 million and a market cap of $504.55 million. The company is currently operating at a loss, with a net profit of -$11 million.

Overview:<BR>OrthoPediatrics Corp. is a medical device company focused on providing product offerings to the pediatric orthopedic market for children with orthopedic conditions, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 52 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -11 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 504.55 Million (Micro Cap) <BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: 0.05 <BR>Return on Equity: -9.19% <BR>Price to Book: 1.45 <BR><BR>Contact Details:<BR>Address: 2850 Frontier Dr, WARSAW IN: 46582-7001 <BR>Tel: ['1 574 2686379', '1 646 5367035'] <BR>Fax: 1 302 6555049 <BR>Website: http://www.orthopediatrics.com/

Should I buy, sell or hold OrthoPediatrics Corp.?

Who are in the management team of OrthoPediatrics Corp.?

As of March 2022, the management team of OrthoPediatrics Corp. includes Mr. Terry Schlotterback (Independent Chairman), Mr. Mark Throdahl (CEO), Mr. Fred Hite (CFO and COO), and several directors including Mr. David Pelizzon, Mr. Harald Ruf, Mr. Bernie Berry, Mr. Stephen Burns, and Mr. Bryan Hughes. They oversee the company's operations and strategic direction.

As of March 2022, the management team of OrthoPediatrics Corp. includes the following individuals:<BR><BR>- Mr. Terry Schlotterback, Independent Chairman of the Board<BR>- Mr. Mark Throdahl, Chief Executive Officer and Director<BR>- Mr. Fred Hite, Chief Financial Officer, Chief Operating Officer, and Director<BR>- Mr. David Pelizzon, Director<BR>- Mr. Harald Ruf, Director<BR>- Mr. Bernie Berry, Independent Director<BR>- Mr. Stephen Burns, Independent Director<BR>- Mr. Bryan Hughes, Independent Director<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

Is OrthoPediatrics Corp. overvalued or undervalued?

As of November 6, 2023, OrthoPediatrics Corp. is considered overvalued and risky due to negative financial metrics and significant underperformance compared to the S&P 500, with a year-to-date return of -13.24% and a 33.10% decline over the past year.

As of 6 November 2023, OrthoPediatrics Corp. has moved from a fair to a risky valuation grade. The company appears to be overvalued given its negative financial metrics, including a Price to Book Value of 1.51, an EV to EBIT of -17.60, and an EV to Sales ratio of 2.55. Comparatively, peers such as Avanos Medical, Inc. have a positive P/E ratio of 9.80, while SI-BONE, Inc. shows a more concerning EV to EBITDA of -25.89, indicating that OrthoPediatrics is not the most attractive option in its sector.<BR><BR>The company's stock has underperformed relative to the S&P 500, with a year-to-date return of -13.24% compared to the index's 12.22%. Over the past year, the stock has declined by 33.10%, while the S&P 500 has gained 17.14%, reinforcing the notion that OrthoPediatrics is struggling in the current market environment.

Is OrthoPediatrics Corp. technically bullish or bearish?

As of August 26, 2025, OrthoPediatrics Corp. shows a mildly bearish technical trend, with mixed indicators across different timeframes, and has underperformed the S&P 500 with year-to-date and one-year returns of -13.24% and -33.10%, respectively.

As of 26 August 2025, the technical trend for OrthoPediatrics Corp. has changed from bearish to mildly bearish. The weekly MACD is mildly bullish, while the monthly MACD is also mildly bullish. However, the daily moving averages are bearish, and the Bollinger Bands indicate a mildly bearish stance on the weekly and bearish on the monthly. The KST shows a mildly bullish signal weekly but bearish monthly, and the OBV is mildly bearish weekly with no trend monthly. Overall, the technical stance is mildly bearish.<BR><BR>In terms of performance, OrthoPediatrics has underperformed the S&P 500 across multiple periods, with a year-to-date return of -13.24% compared to the S&P 500's 12.22%, and a one-year return of -33.10% versus the S&P 500's 17.14%.